2003

22.12.2003

GENESIS RESEARCH AND CORIXA PROVIDE UPDATE ON PVAC™ TREATMENT PROGRAMME

17.12.2003
GENESIS RESEARCH TRANSFERS PLANT SCIENCE BUSINESS TO AGRIGENESIS BIOSCIENCES

10.09.2003
GENESIS AND SR PHARMA INITIATE PHASE II TRIAL OF AVAC™ IN CHILDHOOD ECZEMA

06.08.2003
GENESIS RESEARCH ANNOUNCES HALF YEAR RESULT

05.08.2003
GENESIS RESEARCH APPOINTS CHIEF EXECUTIVE TO NEW PLANT SUBSIDIARY, AGRIGENESIS

14.04.2003
RESULTS OF RESOLUTIONS SUBMITTED TO ANNUAL MEETING

14.04.2003
GENESIS AND EVOGENIX TO COLLABORATE ON DISCOVERY OF NOVEL ANTI-INFLAMMATORIES

24.03.2003
ADDITIONAL BUSINESS TO BE CONSIDERED AT ANNUAL MEETING

05.03.2003
WRIGHTSON SEEK ACQUISITION OF 19.9% OF GENESIS STOCK

05.03.2003
GENESIS RESEARCH ANNOUNCES RESULTS OF PHASE I SAFETY STUDY IN ATOPIC DERMATITIS

05.03.2003
GENESIS AWARDED $800,000 GRANT FOR SOFTWARE DEVELOPMENT INITIATIVE

07.02.2003
GENESIS MAINTAINS CASH RESERVES OF $36.3M TO FUND ONGOING RESEARCH PROGRAMMES

[Home]